Learn about the ISN’s work in advocacy below.
European Commission’s Pharmaceutical Strategy to Tackle Unmet Kidney Care Needs
The ISN welcomes the European Commission’s “Pharmaceutical Strategy for Europe,” released on November 25, 2020. Aspects of the strategy’s objectives are reflective of ISN’s vision of equitable access to kidney health and include: Re-thinking policies to stimulate innovation in areas of need, and patient-centered, health system-oriented pharmaceutical innovation to address long-term care settings. Investing in research and...
Hemodialysis Laughter Therapy in Australia
To honor 2020 as the Year of the Nurse and the Midwife, the ISN continues to present accounts from nurses around the world: Laughing as a group while on dialysis sounds a little strange. How can you pretend to laugh? How can you laugh when you’re in pain, feel tired, and are stuck to a...
ISN President Encourages Patient-Centric NCD Policies
ISN President, Vivekanand Jha, spoke at the online event “Leaving No-one Behind: The Need for a Person-Centred, Inclusive NCD Agenda Confirmation” organized by the NCD Alliance on November 5, 2020. This roundtable event focused on the challenges of the current NCD response and key opportunities and solutions to go beyond a siloed NCD agenda, notably...
ISN Urges Continued Efforts to Prioritize NCDs at World Health Assembly
The ISN participated in the resumed 73rd World Health Assembly (WHA) organized by the WHO, which took place virtually from November 9-14, 2020. The ISN submitted three statements focusing on: The prevention and control of kidney disease and other NCDs. Maternal, infant, and young child nutrition. WHO’s work in health emergencies. Recordings of the sessions, including the statements presented...